{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T18:25:44Z","timestamp":1791397544507,"version":"4.3.3"},"reference-count":50,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2009,11,3]],"date-time":"2009-11-03T00:00:00Z","timestamp":1257206400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"DOI":"10.1371\/journal.pntd.0000542","type":"journal-article","created":{"date-parts":[[2009,11,2]],"date-time":"2009-11-02T21:48:22Z","timestamp":1257198502000},"page":"e542","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":104,"title":["Development of a Mouse Monoclonal Antibody Cocktail for Post-exposure Rabies Prophylaxis in Humans"],"prefix":"10.1371","volume":"3","author":[{"given":"Thomas","family":"M\u00fcller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard","family":"Dietzschold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hildegund","family":"Ertl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony R.","family":"Fooks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Conrad","family":"Freuling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Fehlner-Gardiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeannette","family":"Kliemt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francois X.","family":"Meslin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles E.","family":"Rupprecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"No\u00ebl","family":"Tordo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander I.","family":"Wanderler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie Paule","family":"Kieny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2009,11,3]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"3268","DOI":"10.1128\/JVI.75.7.3268-3276.2001","article-title":"Evidence of two Lyssavirus phylogroups with distinct pathogenicity and immunogenicity.","volume":"75","author":"H Badrane","year":"2001","journal-title":"J Virol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.virusres.2005.03.008","article-title":"Phylogenetic relationships of Irkut and West Caucasian bat viruses within the Lyssavirus genus and suggested quantitative criteria based on the N gene sequence for lyssavirus genotype definition.","volume":"111","author":"IV Kuzmin","year":"2005","journal-title":"Virus Res"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.virusres.2008.04.021","article-title":"Complete genomes of Aravan, Khujand, Irkut and West Caucasian bat viruses, with special attention to the polymerase gene and non-coding regions.","volume":"136","author":"IV Kuzmin","year":"2008","journal-title":"Virus Res"},{"key":"ref4","article-title":"WHO Expert Consultation on Rabies, First Report,","volume":"931","year":"2005"},{"key":"ref5","first-page":"360","article-title":"Re-evaluating the burden of rabies in Africa and Asia.","volume":"83","author":"DL Knobel","year":"2005","journal-title":"Bull World Health Organ"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"211","DOI":"10.2807\/esm.10.11.00574-en","article-title":"Rabies remains a \u2018neglected disease\u2019.","volume":"10","author":"AR Fooks","year":"2005","journal-title":"Eurosurveillance"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"136","DOI":"10.3201\/eid1301.060810","article-title":"Rabies encephalitis in malaria-endemic area, Malawi, Africa.","volume":"13","author":"M Mallewa","year":"2007","journal-title":"Emerg Infect Dis"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.3201\/eid1112.050271","article-title":"Pivotal role of dogs in rabies transmission, China.","volume":"11","author":"X Tang","year":"2005","journal-title":"Emerg Infect Dis"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"7252","DOI":"10.1073\/pnas.89.15.7252","article-title":"Delineation of putative mechanisms involved in antibody-mediated clearance of rabies virus from the central nervous system.","volume":"89","author":"B Dietzschold","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1099\/0022-1317-64-4-843","article-title":"Antigenic sites on the CVS rabies virus glycoprotein: analysis with monoclonal antibodies.","volume":"64","author":"M Lafon","year":"1983","journal-title":"J Gen Virol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1172\/JCI114260","article-title":"Use of mouse anti-rabies monoclonal antibodies in postexposure treatment of rabies.","volume":"84","author":"CL Schumacher","year":"1989","journal-title":"J Clin Invest"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/BF03259250","article-title":"Monoclonal antibodies in rabies therapy.","volume":"1","author":"B Dietzschold","year":"1994","journal-title":"Clin Immunother"},{"key":"ref13","article-title":"WHO recommendations on rabies post-exposure treatment and the correct technique of intradermal immunization against rabies.","year":"1997"},{"key":"ref14","first-page":"731","article-title":"Purified equine rabies immune globulin: a safe and affordable alternative to human rabies immune globulin.","volume":"67","author":"H Wilde","year":"1989","journal-title":"Bull World Health Organ"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/0264-410X(89)90003-0","article-title":"Adverse effects of equine rabies immune gobulin.","volume":"7","author":"H Wilde","year":"1989","journal-title":"Vaccine"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0022-1759(99)00223-9","article-title":"The development of monoclonal human rabies virus-neutralizing antibodies as a substitute for pooled human immune globulin in the prophylactic treatment of rabies virus exposure.","volume":"235","author":"JM Champion","year":"2000","journal-title":"J Immunol Methods"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1001\/jama.1982.03320430003001","article-title":"Monoclonal antibodies: key to a revolution in clinical medicine.","volume":"247","author":"C Macek","year":"1982","journal-title":"JAMA"},{"key":"ref18","first-page":"663","article-title":"The use of antibodies in the treatment of infectious diseases.","volume":"50","author":"CEZ Chan","year":"2009","journal-title":"Singapore Med J"},{"key":"ref19","first-page":"199","article-title":"Future prospects in antibody engineering and therapy.","author":"S Siberil","year":"2004"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.1128\/JVI.64.6.3087-3090.1990","article-title":"Biological characterization of human monoclonal antibodies to rabies virus.","volume":"64","author":"B Dietzschold","year":"1990","journal-title":"J Virol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1089\/hyb.1994.13.397","article-title":"Development of human monoclonal antibodies to rabies.","volume":"13","author":"N Dorfman","year":"1994","journal-title":"Hybridoma"},{"key":"ref22","first-page":"195","article-title":"Production of human monoclonal antibodies against rabies virus.","volume":"187","author":"RF Rando","year":"1994","journal-title":"Curr Top Microbiol Immunol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"3834","DOI":"10.1016\/S0264-410X(01)00135-9","article-title":"Experimental utility of rabies virus-neutralizing human monoclonal antibodies in post-exposure prophylaxis.","volume":"19","author":"CA Hanlon","year":"2001","journal-title":"Vaccine"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.1016\/j.vaccine.2006.12.031","article-title":"Identification and characterization of a human monoclonal antibody that potently neutralizes a broad panel of rabies virus isolates.","volume":"25","author":"SE Sloan","year":"2007","journal-title":"Vaccine"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"192","DOI":"10.4161\/hv.3.5.4386","article-title":"Use of neutralizing murine monoclonal antibodies to rabies glycoprotein in passive immunotherapy against rabies.","volume":"3","author":"K Muhamuda","year":"2007","journal-title":"Hum Vaccin"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1128\/JVI.73.1.225-233.1999","article-title":"Chimeric lyssavirus glycoproteins with increased immunological potential.","volume":"73","author":"C Jallet","year":"1999","journal-title":"J Virol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"9062","DOI":"10.1128\/JVI.79.14.9062-9068.2005","article-title":"Novel human monoclonal antibody combination effectively neutralizing natural rabies viru variants and individual in vitro escape mutants.","volume":"79","author":"AB Bakker","year":"2005","journal-title":"J Virol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1086\/500470","article-title":"Comparison of an anti-rabies human monoclonal antibody combination with human polyclonal anti-rabies immune globulin.","volume":"193","author":"J Goudsmit","year":"2006","journal-title":"J Infect Dis"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"5922","DOI":"10.1016\/j.vaccine.2008.08.050","article-title":"First administration to humans of a monoclonal antibody cocktail against rabies virus: safety, tolerability, and neutralizing activity.","volume":"26","author":"AB Bakker","year":"2008","journal-title":"Vaccine"},{"key":"ref30","first-page":"535","article-title":"A rapid reproducible test for determining rabies neutralizing antibodies.","volume":"48","author":"JS Smith","year":"1973","journal-title":"Bull World Health Org"},{"key":"ref31","first-page":"79","article-title":"Development of a fluorescent antibody virus neutralisation test (FAVN test) for the quantitation of rabies-neutralising antibody.","volume":"212","author":"F Cliquet","year":"1998","journal-title":"J ImmunolMethods"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1016\/j.vaccine.2008.04.007","article-title":"Genetic characterisation of attenuated SAD rabies virus strains used for oral vaccination of wildlife.","volume":"26","author":"L Geue","year":"2008","journal-title":"Vaccine"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0168-1702(02)00267-8","article-title":"Differential stability and fusion activity of Lyssavirus glycoprotein trimers.","volume":"91","author":"E Desm\u00e9zi\u00e8res","year":"2003","journal-title":"Virus Res"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.biologicals.2005.07.004","article-title":"A simple immuno-capture ELISA to estimate rabies viral glycoprotein antigen in vaccine manufacture.","volume":"34","author":"T Nagarajan","year":"2006","journal-title":"Biologicals"},{"key":"ref35","first-page":"47","article-title":"Application of monoclonal antibodies for epidemiological investigations and oral vaccination studies.","author":"LG Schneider","year":"1985"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0042-6822(87)90167-X","article-title":"Mechanisms of rabies virus neutralization by glycoprotein-specific monoclonal antibodies.","volume":"161","author":"B Dietzschold","year":"1987","journal-title":"Virology"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1128\/jcm.3.2.96-101.1976","article-title":"Prophylactic immunization of humans against rabies by intradermal inoculation of human diploid cell culture vaccine.","volume":"3","author":"JH Cox","year":"1976","journal-title":"J Clin Microbiol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.virusres.2005.03.009","article-title":"Efficacy of rabies biologics against new lyssaviruses from Eurasia.","volume":"111","author":"CA Hanlon","year":"2005","journal-title":"Virus Res"},{"key":"ref39","first-page":"88","article-title":"The fluorescence antibody test.","author":"DJ Dean","year":"1996"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"5429","DOI":"10.1073\/pnas.77.9.5429","article-title":"Human-human hybridomas producing monoclonal antibodies of predefined antigenic specificity.","volume":"77","author":"L Olsson","year":"1980","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1146\/annurev.med.58.061705.145053","article-title":"A human monoclonal antibody cocktail as a novel component of rabies postexposure prophylaxis.","volume":"58","author":"J de Kruif","year":"2007","journal-title":"Annu Rev Med"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0022-1759(01)00353-2","article-title":"High level expression of a human rabies virus-neutralizing monoclonal antibody by a rhabdovirus-based vector.","volume":"252","author":"K Morimoto","year":"2001","journal-title":"J Immunol Methods"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1086\/375247","article-title":"Development of a cocktail of recombinant-expressed human rabies virus-neutralizing monoclonal antibodies for postexposure prophylaxis of rabies.","volume":"188","author":"M Prosniak","year":"2003","journal-title":"J Infect Dis"},{"key":"ref44","article-title":"Immunoglobulins","author":"TA Waldman","year":"1970"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"4101","DOI":"10.1016\/j.vaccine.2005.03.037","article-title":"Rabies human diploid cell vaccine elicits cross-neutralising and cross-protecting immune responses against European and Australian bat lyssaviruses.","volume":"23","author":"SM Brookes","year":"2005","journal-title":"Vaccine"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/0042-6822(83)90349-5","article-title":"Chemical and immunological analysis of the rabies soluble glycoprotein.","volume":"124","author":"B Dietzschold","year":"1983","journal-title":"Virology"},{"key":"ref47","first-page":"199","article-title":"Antigenic analysis of rabies and Mokola virus from Zimbabwe using monoclonal antibodies.","volume":"57","author":"TJ Wiktor","year":"1984","journal-title":"Dev Biol Stand"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1099\/0022-1317-71-8-1689","article-title":"Human monoclonal antibodies specific for the rabies virus glycoprotein and N protein.","volume":"71","author":"M Lafon","year":"1990","journal-title":"J Gen Virol"},{"key":"ref49","first-page":"1619","article-title":"Humanization of antibodies.","volume":"13","author":"JC Almagro","year":"2008","journal-title":"Front Biosci"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1093\/clinids\/10.Supplement_4.S785","article-title":"Antigenic diversity of the glycoprotein and nucleocapsid proteins of rabies and rabies-related viruses: implications for epidemiology and control of rabies.","volume":"10","author":"B Dietzschold","year":"1988","journal-title":"Rev Infect Dis"}],"updated-by":[{"DOI":"10.1371\/annotation\/df98339d-6bdb-40ed-af83-cc38b249264a","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2009,11,10]],"date-time":"2009-11-10T00:00:00Z","timestamp":1257811200000}}],"container-title":["PLoS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pntd.0000542","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,13]],"date-time":"2021-10-13T07:34:44Z","timestamp":1634110484000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0000542"}},"subtitle":[],"editor":[{"given":"Jakob","family":"Zinsstag","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2009,11,3]]},"references-count":50,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2009,11,3]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0000542","relation":{"correction":[{"id-type":"doi","id":"10.1371\/annotation\/df98339d-6bdb-40ed-af83-cc38b249264a","asserted-by":"object"}]},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,11,3]]}}}